Article Details
Retrieved on: 2021-06-07 17:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Global cannabis research company Zelira Therapeutics (ASX: ZLD) (OTCQB:ZLDAF) is set to being a cannabinoid-based clinical trial on chronic pain ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here